PATENT CLAIM ANALYSIS

Application Number: 15927986
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "093300"]

Abstract:
This invention relates to new uses of  Bifidobacteria  (particularly, although not exclusively, probiotic  Bifidobacteria ), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of myocardial infarction and congestive heart failure.

Claim (Index 5):
The method of  claim 1 , wherein the bacterium is of the species selected from the group consisting of  Bifidobacterium lactis, Bifidobacterium bifidium, Bifidobacterium longum, Bifidobacterium animalis, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium catenulatum, Bifidobacterium pseudocatenulatum, Bifidobacterium adolescentis,  and  Bifidobacterium angulatum,  and mixtures of any thereof.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 90.0
- Lexical Diversity: 1.28205
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13384748', '14983827', '15744211', '14457916', '14535241']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8094025174052304
- 35 USC 102 Novelty (BERT): 0.5904173123607449
- Combined Prediction Score: 0.7875039969007819
- Mean Citation Score: 405.798552
- Max Citation Score: 495.96576
- Similarity Product: 482.2699262685013

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test